迪恩ोजे斯特对来自健康和子宫内膜异位症组织的子宫内膜介质干细胞的不同作用
Hayal Uzelli Şimşek1, Turgay Şimşek2, Gökhan Duruksu3,4
1Department of Obstetrics and Gynecology, Kocaeli University Faculty of Medicine, Kocaeli, Türkiye
Balkan medical journal
|September 18, 2024
概括
迪恩奥杰斯特抑制子宫内膜干细胞 (E-MSCs) 的增殖和迁移从子宫内膜异位症患者. 这项研究揭示了dienogest的存在.
科学领域:
- 生殖生物学 生殖生物学
- 干细胞研究的研究.
- 药理学 药理学是指药理学的学科.
背景情况:
- 子宫内膜异位症 (EM) 是一种炎症性疾病,其特征是子宫外的子宫内膜组织.
- 子宫内膜介质干细胞 (E-MSCs) 在子宫内膜组织中发现.
- 丁诺日斯特对E-MSCs的影响尚不清楚.
研究的目的:
- 为了研究化物对健康和子宫内膜异位症患者的E-MSCs的体外影响.
- 评估dienogest如何影响E-MSC增殖,端粒酶活性,迁移和雌激素分泌.
主要方法:
- 从健康的子宫内膜组织和子宫内膜异位症的子宫内膜组织中分离和表征了E-MSCs.
- 在体外对E-MSC进行了dienenogest治疗.
- 测量了细胞增殖,端粒酶活性,迁移和雌激素分泌.
主要成果:
- 来自子宫内膜异位症组织的E-MSC表现出比健康组织的更高的增殖率.
- 在E-MSCs中,迪恩诺杰斯特抑制了增殖和端粒酶活性,特别是在子宫内膜异位症患者中.
- 迪恩格斯特降低了E-MSCs-子宫内膜异位症的迁移能力和雌激素分泌,并降低了高CXCL12和Ki67表达.
结论:
- 迪昂格斯特显著影响子宫内膜干细胞,逆转子宫内膜异位症标志物.
- 该药物通过调节E-MSC行为来有效控制子宫内膜异位症.
- 这些效应即使在E-MSCs上没有孕激素受体的情况下也会发生.
相关概念视频
01:19Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
02:07Oogenesis
63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K